United States· US:61958-3601_1da44bad-4470-4f3d-b7b2-bc3730f496d1
BIXLENVO
A medicinal product containing bictegravir sodium; lenacapavir sodium, registered in United States by Gilead Sciences, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM
- Manufacturer
- Gilead Sciences, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1161958-3601-1
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/023a7210-f4d5-4f5f-9371-a737e0d948c0 GET /v1/drugs/023a7210-f4d5-4f5f-9371-a737e0d948c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "75; 50",
"substance": "BICTEGRAVIR SODIUM; LENACAPAVIR SODIUM",
"productndc": "61958-3601",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA221104",
"marketing_category": "NDA"
}See everything about bictegravir sodium; lenacapavir sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.